A New Approach to Block Treatment Resistance in Metastatic TNBC and Her2+ Breast Cancer

Integrin αvβ3 Is a Master Regulator of Resistance to TKI-Induced Ferroptosis in HER2-Positive Breast Cancer

A Nagpal, K Needham, DJR Lane, S Ayton, RP Redvers, M John, HS Selistre-de-Araujo, D Denoyer, N Pouliot

2023-02-01

Human epidermal growth factor receptor-2 (HER2)-targeting therapies provide clinical benefits for patients with HER2-positive brea..